CTSO
Price:
$0.92
Market Cap:
$50.31M
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention and treatment of perioperative complications of cardiopulmonary bypass surgery, and maintaining or enhancing the quality of solid organs harvested from donors for organ transplant. The company also develops VetResQ, a device for adjunctive therapy in the treatment of sepsis, pancreatitis, and...[Read more]
Industry
Medical - Devices
IPO Date
2006-08-08
Stock Exchange
NASDAQ
Ticker
CTSO
According to Cytosorbents Corporation’s latest financial reports and current stock price. The company's current ROE is -13069.04%. This represents a change of 189.79% compared to the average of -4509.80% of the last 4 quarters.
The mean historical ROE of Cytosorbents Corporation over the last ten years is 117.19%. The current -13069.04% ROE has changed -11251.74% with respect to the historical average. Over the past ten years (40 quarters), CTSO's ROE was at its highest in in the December 2016 quarter at 931.18%. The ROE was at its lowest in in the September 2024 quarter at -17955.80%.
Average
117.19%
Median
-95.90%
Minimum
-563.66%
Maximum
2.52%
Discovering the peaks and valleys of Cytosorbents Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 454.61%
Maximum Annual ROE = 2.52%
Minimum Annual Increase = -2642.70%
Minimum Annual ROE = -563.66%
Year | ROE | Change |
---|---|---|
2023 | -122.48% | 32.04% |
2022 | -92.76% | 136.35% |
2021 | -39.25% | 296.69% |
2020 | -9.89% | -98.24% |
2019 | -563.66% | 454.61% |
2018 | -101.63% | 23.28% |
2017 | -82.44% | -103.27% |
2016 | 2.52% | -2642.70% |
2015 | -99.04% | -57.89% |
2014 | -235.20% | -817.27% |
The current ROE of Cytosorbents Corporation (CTSO) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-84.83%
5-year avg
-165.61%
10-year avg
117.19%
Cytosorbents Corporation’s ROE is less than ProSomnus, Inc. Common Stock (50.75%), less than LivaNova PLC (1.88%), less than Electromed, Inc. (15.32%), less than OrthoPediatrics Corp. (-7.64%), less than Surmodics, Inc. (-9.56%), greater than NeuroPace, Inc. (-205.41%), less than ClearPoint Neuro, Inc. (-62.10%), greater than TELA Bio, Inc. (-556.18%), less than CVRx, Inc. (-89.06%), less than Orthofix Medical Inc. (-21.25%), less than Artivion, Inc. (-0.29%), less than Heska Corporation (-4.29%), less than Paragon 28, Inc. (-38.77%), less than Inogen, Inc. (-27.38%), less than Pulmonx Corporation (-53.88%), greater than Apyx Medical Corporation (-156.40%),
Company | ROE | Market cap |
---|---|---|
50.75% | $8.18M | |
1.88% | $2.79B | |
15.32% | $251.96M | |
-7.64% | $637.85M | |
-9.56% | $561.12M | |
-205.41% | $289.53M | |
-62.10% | $326.46M | |
-556.18% | $118.56M | |
-89.06% | $360.32M | |
-21.25% | $722.63M | |
-0.29% | $1.19B | |
-4.29% | $1.31B | |
-38.77% | $838.76M | |
-27.38% | $223.42M | |
-53.88% | $268.12M | |
-156.40% | $54.40M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cytosorbents Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cytosorbents Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Cytosorbents Corporation's ROE?
How is the ROE calculated for Cytosorbents Corporation (CTSO)?
What is the highest ROE for Cytosorbents Corporation (CTSO)?
What is the 3-year average ROE for Cytosorbents Corporation (CTSO)?
What is the 5-year average ROE for Cytosorbents Corporation (CTSO)?
How does the current ROE for Cytosorbents Corporation (CTSO) compare to its historical average?